Credit: Courtesy of Dr. Robert Abbott, La Jolla Institute for Allergy and Immunology
Naïve precursor B cells that can give rise to mature B cells producing broadly neutralizing antibodies—a requirement for a successful antibody-based HIV vaccine—successfully compete in a germinal center following immunization with a high-affinity germline targeting nanoparticle.